Abstract
Non-invasive Assessment of Pathological Complete Response and Minimal Residual Disease Through Plasma Methylomics in Patients With Triple Positive Breast Cancer
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have